Cargando…
Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective study
BACKGROUND: Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs historically have prolonged OS. Pancreatic metastases are uncommon overall, with mRCC being the most common etiology of pancreatic metast...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248040/ https://www.ncbi.nlm.nih.gov/pubmed/37304495 http://dx.doi.org/10.1016/j.eclinm.2023.102018 |